Literature DB >> 2141333

Tumor necrosis factor up-regulates gamma-interferon binding in a human carcinoma cell line.

A B Raitano1, M Korc.   

Abstract

WiDR colorectal carcinoma cells are highly sensitive to the synergistic cytotoxic effects of tumor necrosis factor (TNF) and gamma-interferon (IFN-gamma). In the present study, we have investigated the effects of recombinant human (rh) TNF and IFN-gamma on the binding of both ligands in this cell line. WiDR cells exhibited high affinity binding sites for both 125I-rhTNF (Kd = 1.66 x 10(-10) M, 920 sites/cell) and 125I-rhIFN-gamma (Kd = 4.15 x 10(-10) M, 18,960 sites/cell). Preincubation of the cells with rhTNF (24 h) increased cell-associated 125I-rhIFN-gamma radioactivity by 129% when binding was carried out at 37 degrees C, as a result of an increase in both surface bound and internalized 125I-rhIFN-gamma. However, rhTNF did not alter the degradation profile of released 125I-rhIFN-gamma radioactivity. Scatchard analysis of 125I-rhIFN-gamama binding data (4 degrees C) revealed that rhTNF induced a 245% increase in 125I-rhIFN-gamma binding sites. Conversely, rhIFN-gamma caused a 68% increase in 125I-rhTNF binding sites and a 58% increase in receptor affinity. rhIFN-gamma also increased the subsequent binding of 125I-rhIFN-gamma, whereas rhTNF increased the subsequent binding of 125I-rhTNF. Furthermore, preincubation of the cells with both rhTNF and rhIFN-gamma also resulted in an increase in the binding of both ligands. Actinomycin D and cycloheximide blocked all the effects of rhTNF and rhIFN-gamma on ligand binding. However, the basal level of 125I-rhIFN-gamma binding was insensitive to either inhibitor, whereas the basal level of 125I-rhTNF binding was decreased by both inhibitors. These data indicate that in some cell types TNF and IFN-gamma may induce an increase in their own receptors (homologous up-regulation) and concomitantly increase each other's receptors (heterologous up-regulation) and that these actions are due, in part, to enhanced receptor synthesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2141333

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on fibroblast-like synoviocytes: paradoxical induction of IFN-gamma and TNF-alpha receptor expression.

Authors:  J M Alvaro-Gracia; C Yu; N J Zvaifler; G S Firestein
Journal:  J Clin Immunol       Date:  1993-05       Impact factor: 8.317

2.  Overexpression of activin A in stage IV colorectal cancer.

Authors:  S Wildi; J Kleeff; H Maruyama; C A Maurer; M W Büchler; M Korc
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

3.  Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum.

Authors:  M Kornmann; N Arber; M Korc
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

4.  14-3-3sigma Modulates pancreatic cancer cell survival and invasiveness.

Authors:  Divas Neupane; Murray Korc
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

5.  The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.

Authors:  J Kleeff; T Ishiwata; A Kumbasar; H Friess; M W Büchler; A D Lander; M Korc
Journal:  J Clin Invest       Date:  1998-11-01       Impact factor: 14.808

6.  Expression of interferon-gamma receptors on bladder cancer cells: does it correlate with biological response?

Authors:  S J Hawkyard; A M Jackson; R A Hawkins; K James; J F Smyth; G D Chisholm
Journal:  Urol Res       Date:  1992

7.  Cytokine effects in a human colonic goblet cell line. Cellular damage and its partial prevention by 5 aminosalicylic acid.

Authors:  A Jarry; F Muzeau; C Laboisse
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

Review 8.  Changes in the immune system in depression and dementia: causal or coincidental effects?

Authors:  Brian E Leonard; Ayemu Myint
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

9.  HLA-DR antigen expression in colorectal carcinomas: influence of expression by IFN-gamma in situ and its association with tumour progression.

Authors:  K Matsushita; T Takenouchi; S Kobayashi; H Hayashi; K Okuyama; T Ochiai; A Mikata; K Isono
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

10.  Interferon γ-induced intratumoral expression of CXCL9 alters the local distribution of T cells following immunotherapy with Listeria monocytogenes.

Authors:  Patrick Guirnalda; Laurence Wood; Radhika Goenka; Joel Crespo; Yvonne Paterson
Journal:  Oncoimmunology       Date:  2013-07-23       Impact factor: 8.110

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.